Effectiveness and healthcare costs among stabilised rheumatoid arthritis patients with dose reduction of adalimumab or etanercept in real world.

Yang, Min

Effectiveness and healthcare costs among stabilised rheumatoid arthritis patients with dose reduction of adalimumab or etanercept in real world. [electronic resource] - Clinical and experimental rheumatology - 791-798 p. digital

Publication Type: Comparative Study; Journal Article

0392-856X


Adalimumab--administration & dosage
Administrative Claims, Healthcare
Antirheumatic Agents--administration & dosage
Arthritis, Rheumatoid--diagnosis
Biological Products--administration & dosage
Cost-Benefit Analysis
Databases, Factual
Drug Administration Schedule
Drug Costs
Etanercept--administration & dosage
Female
Humans
Male
Middle Aged
Models, Economic
Multivariate Analysis
Retrospective Studies
Time Factors
Treatment Outcome
United States